-
Bank Ranking
Banks Ratios
Cement Statistics
Cement Ranking
Cement Ratios
Monetary and Economic Statistics
Oil, Gas and Fuel
Macro Economy
Consumer Spending
Inflation
Exports & Imports
Food Prices
Non Food Prices
Construction Materials
Petrochem. Ranking
Petrochem. Ratios
Retail Rankings
Retail Ratios
Grocery Ranking
Grocery Ratios
Top Growth
Dividend History
SPIMACO shareholders to vote on 6% cash dividend for 2021 on June 8
Saudi Pharmaceutical Industries & Medical Appliances Corp.’s (SPIMACO) shareholders will vote on the board of directors’ recommendation to distribute a 6% cash dividend, or SAR 0.6 a share, for 2021, during the ordinary general assembly meeting (OGM) to be held on June 8.
|
Dividend Details ( 2021) |
|
|
Current capital |
SAR 1.2 bln |
|
Number of shares |
120 mln |
|
Dividend |
SAR 72 mln |
|
Percentage of capital |
6% (SAR 0.6 per share) |
|
Record date |
Shareholders registered with the Securities Depository Center (Edaa) by the end of the second trading day following the general assembly meeting (June 8) |
|
Payment date |
To be determined |
In a statement to Tadawul, SPIMACO said the shareholders will also vote to authorize the board to distribute interim dividends for 2022 on a quarterly or semi-annual basis, along with determining the due date and disbursement, in line with the company's financial position, cash flows, expansion and investment plans.
The meeting agenda also includes voting on board and auditor reports for 2021, along with the financial statements for the same year.
The shareholders will also vote on the business and contracts that will be concluded between the SPIMACO and Arab Company for Drug Industries and Medical Appliances (ACDIMA), in which board members Adel Kareem Ahmed and Mohammed Khalil Mohammed have an indirect interest.
Adel Ahmed is the Chairman of ACDIMA and Mohammed Khalil is the Director General.
The business and contracts are represented in a share purchase agreement between SPIMACO and ACDIMA, for the purchase of shares owned by ACDIMA in CAD Middle East Pharmaceutical Industries for SAR 10.53 million, without preferential terms.
The shareholders will also vote on paying an SAR 4.65 million as remuneration to board and committees members for 2021.
Dividend History (SAR/share) Corporate Actions
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 24/03/2022 | 08/06/2022 | 27/06/2022 | 72.00 | 0.60 | |
| 23/03/2021 | 30/05/2021 | 16/06/2021 | 120.00 | 1.00 | |
| 31/03/2020 | 14/05/2020 | 11/06/2020 | 60.00 | 0.50 | |
| 05/03/2019 | 02/04/2019 | 18/04/2019 | 120.00 | 1.00 | |
| 31/07/2018 | 30/08/2018 | 20/09/2018 | 60.00 | 0.50 | |
| 22/03/2018 | 19/04/2018 | 03/05/2018 | 120.00 | 1.00 | |
| 12/03/2017 | 16/04/2017 | 11/05/2017 | 120.00 | 1.00 | |
| 16/02/2016 | 03/04/2016 | 28/04/2016 | 120.00 | 1.00 | |
| 17/02/2015 | 23/04/2015 | 14/05/2015 | 180.00 | 1.50 | |
| 23/02/2014 | 17/04/2014 | 11/05/2014 | 78.44 | 0.65 |
Dividend History
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | 1.60 | 27.50 | 5.82 % |
| Last 5 Financial years | 3.60 | 30.44 | 11.83 % |
| Last 10 Financial years | 8.75 | 28.76 | 30.44 % |
Most Read
- GCC fund passporting unlocks investment potential: Fitch
- Half of units offered in Diriyah under several brands sold: DGDA CEO
- Goldman Sachs expects oil prices to average $76 in 2025
- Maaden offers SAR 4B investment opportunities for private sector
- Military spending in Saudi Arabia 19.4% localized: GAMI
Valuation Data (Latest Share Price)
| P/E (TTM) | More than 100 |
| P/E Before Unusual Items (TTM) | More than 100 |
| P/BV | 2.53 |
| Dividend Yield | - |
| Market Cap. (M) | 3,732.00 |
| Return on Average Assets | 0.27 % |
| Return on Average Equity | 0.77 % |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}